[新诊断的ADHD的年轻成年人中甲基胺诱导的精神病:一个案例报告]
Ragna Kristin Gudbrandsdottir1, Engilbert Sigurdsson2, Oddur Ingimarsson2
1Faculty of Medicine, University of Iceland.
Laeknabladid
|June 28, 2023
概括
成人ADHD药物,如甲基,很少会导致精神病. 医生应该意识到这种严重的不良反应,特别是冰岛处方增加.
科学领域:
- 精神病学是一个精神病学.
- 药理学 药理学是指药理学的学科.
- 神经科学是一个神经科学.
背景情况:
- 成年注意力缺陷/多动症 (ADHD) 诊断和兴奋剂处方在全球范围内增加,包括在冰岛.
- 在2022年,5%的冰岛成年人接受了多动症药物治疗,强调了对潜在不良影响的警需要.
- 精神病是一种已知的但罕见的不良反应,与用于ADHD的兴奋剂药物有关.
研究的目的:
- 在没有精神疾病病史的成年人中报告甲基胺诱导的精神病症.
- 提高医疗保健专业人员对在ADHD治疗期间可能出现严重精神疾病不良事件的认识.
- 为了强调监测患者精神病症状的重要性,医生为ADHD处方兴奋剂药物.
主要方法:
- 案例报告的呈现方式.
- 对临床表现和患者病史的审查.
- 药物和不良事件关系的分析.
主要成果:
- 一名年轻的成年男性在开始治疗Methylphenidate治疗ADHD后出现了急性精神病.
- 该患者以前没有精神疾病或精神病发作史.
- 精神病症状需要进入精神病重症监护室,在停止服用药物后得到缓解.
结论:
- 甲基胺可以诱导精神病,即使在没有先前精神病史的个体中也是如此.
- 医疗保健提供者必须考虑精神病是ADHD兴奋剂药物的潜在不良影响.
- 及时识别和管理,包括停药,对于解决兴奋剂诱导的精神病至关重要.
更多相关视频
05:52Handwriting Analysis Indicates Spontaneous Dyskinesias in Neuroleptic Naïve Adolescents at High Risk for Psychosis
Published on: November 21, 2013
15.0K
05:48The Adventures of Fundi Intervention Based on the Cognitive and Emotional Processing in Attention Deficit Hyperactive Disorder Patients
Published on: June 12, 2020
5.8K
相关概念视频
01:30Attention-Deficit/Hyperactivity Disorder
133
Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by persistent inattention, hyperactivity, and impulsivity. It affects approximately 5-8% of children globally, with around 60-70% of cases persisting into adulthood. ADHD has significant implications for educational attainment, social interactions, and occupational success.
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
133
01:28Psychosis and Antipsychotic Drugs: Overview
348
The term "psychosis" refers to a spectrum of mental disorders characterized by abnormal thoughts, perceptions, and behaviors. It can manifest as mood disorders, dementia, delirium with psychotic features, substance-induced psychosis with psychotic features, brief psychotic disorder, delusional disorder, schizoaffective disorder, and schizophrenia. Among all these disorders, schizophrenia is the most common psychotic disorder, affecting 1% of the worldwide population. Psychotic...
348
01:26Psychosis: Goals of Pharmacotherapy
171
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
171
01:27Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders
763
Schizophrenia is a neurodevelopmental disorder whose origins are rooted in complex genetic components. Despite our burgeoning understanding, the pathophysiology of this disorder remains incompletely deciphered.
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
763
01:28Drug Therapy
74
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
74
01:17Schizophrenia
150
Schizophrenia, a term introduced by Swiss psychiatrist Eugen Bleuler in 1911, describes a severe psychological disorder marked by profound disruptions in attention, thought processes, language, emotion, and interpersonal relationships. The core feature of schizophrenia is psychosis — a state characterized by a fundamental detachment from reality. This disconnection manifests through distorted logic, impaired perception, and atypical behavior, severely affecting the lives of those...
150